Preparation of Small-Diameter Tissue-Engineered Vascular Grafts Electrospun from Heparin End-Capped PCL and Evaluation in a Rabbit Carotid Artery Replacement Model.

Aiming to construct small diameter (ID <6 mm) off-the-shelf tissue-engineered vascular grafts, the end-group heparinizd poly(ε-caprolactone) (PCL) is synthesized by a three-step process and then electrospun into an inner layer of double-layer vascular scaffolds (DLVSs) showing a hierarchical double distribution of nano- and microfibers. Afterward, PCL without the end-group heparinization is electrospun into an outer layer. A steady release of grafted heparin and the existence of a glycocalyx structure give the grafts anticoagulation activity and the conjugation of heparin also improves hydrophilicity and accelerates degradation of the scaffolds. The DLVSs are evaluated in six rabbits via a carotid artery interpositional model for a period of three months. All the grafts are patent until explantation, and meanwhile smooth endothelialization and fine revascularization are observed in the grafts. The composition of the outer layer of scaffolds exhibits a significant effect on the aneurysm dilation after implantation. Only one aneurysm dilation is detected at two months and no calcification is formed in the follow-up term. How to prevent aneurysms remains a challenging topic.

[1]  L. Ye,et al.  Vascular Remodeling Process of Heparin-Conjugated Poly(ε-Caprolactone) Scaffold in a Rat Abdominal Aorta Replacement Model , 2018, Journal of Vascular Research.

[2]  Yadong Wang,et al.  Quickening: Translational design of resorbable synthetic vascular grafts. , 2018, Biomaterials.

[3]  Feng Zhao,et al.  Tissue Engineering at the Blood‐Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development , 2018, Advanced healthcare materials.

[4]  S. Van Vlierberghe,et al.  Endothelialization and Anticoagulation Potential of Surface-Modified PET Intended for Vascular Applications. , 2018, Macromolecular bioscience.

[5]  V. Hasırcı,et al.  PCL and PCL-based materials in biomedical applications , 2018, Journal of biomaterials science. Polymer edition.

[6]  J. Rachon,et al.  Synthesis and antimicrobial activity of amino acid and peptide derivatives of mycophenolic acid , 2017, European Journal of Medicinal Chemistry.

[7]  N. Hibino,et al.  Review of Vascular Graft Studies in Large Animal Models. , 2017, Tissue engineering. Part B, Reviews.

[8]  L. Ye,et al.  The penetration and phenotype modulation of smooth muscle cells on surface heparin modified poly(ɛ-caprolactone) vascular scaffold. , 2017, Journal of biomedical materials research. Part A.

[9]  Nicholas A. Kurniawan,et al.  Vascular Mechanobiology: Towards Control of In Situ Regeneration , 2017, Cells.

[10]  C. Breuer,et al.  Fast‐degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft , 2017, Journal of vascular surgery.

[11]  Lisa D. Muiznieks,et al.  Biomaterials and Modifications in the Development of Small-Diameter Vascular Grafts. , 2017, ACS biomaterials science & engineering.

[12]  Daniel E. Heath,et al.  Promoting Endothelialization of Polymeric Cardiovascular Biomaterials , 2017 .

[13]  M. Eppihimer,et al.  Anti-thrombotic technologies for medical devices. , 2017, Advanced drug delivery reviews.

[14]  R. Biran,et al.  Heparin coatings for improving blood compatibility of medical devices☆ , 2017, Advanced drug delivery reviews.

[15]  N. Hibino,et al.  Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model , 2016, PloS one.

[16]  Shaoyang Ma,et al.  Three-Layered PCL Grafts Promoted Vascular Regeneration in a Rabbit Carotid Artery Model. , 2016, Macromolecular bioscience.

[17]  Jong-Chul Park,et al.  Enhanced Patency and Endothelialization of Small-Caliber Vascular Grafts Fabricated by Coimmobilization of Heparin and Cell-Adhesive Peptides. , 2016, ACS applied materials & interfaces.

[18]  S. Gui,et al.  The Expression of Estrogen Receptor Subtypes in Prolactinomas and Their Relationship to Tumor Biological Behavior. , 2015, Biomedical and environmental sciences : BES.

[19]  Nan Ma,et al.  Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications. , 2015, Chemical Society reviews.

[20]  A. Boccaccini,et al.  Vascularisation for cardiac tissue engineering: the extracellular matrix , 2014, Thrombosis and Haemostasis.

[21]  Kevin A. Rocco,et al.  In vivo applications of electrospun tissue-engineered vascular grafts: a review. , 2014, Tissue engineering. Part B, Reviews.

[22]  Kevin A. Rocco,et al.  Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model. , 2014, Atherosclerosis.

[23]  Qiang Zhao,et al.  Improvement of cell infiltration in electrospun polycaprolactone scaffolds for the construction of vascular grafts. , 2014, Journal of biomedical nanotechnology.

[24]  Qiang Zhao,et al.  The effect of thick fibers and large pores of electrospun poly(ε-caprolactone) vascular grafts on macrophage polarization and arterial regeneration. , 2014, Biomaterials.

[25]  Kevin A. Rocco,et al.  In vivo applications of electrospun tissue-engineered vascular grafts: a review. , 2014, Tissue engineering. Part B, Reviews.

[26]  Kai Wang,et al.  Effect of sustained heparin release from PCL/chitosan hybrid small-diameter vascular grafts on anti-thrombogenic property and endothelialization. , 2014, Acta biomaterialia.

[27]  Haibo Zhang,et al.  Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering , 2014, International journal of nanomedicine.

[28]  Silvia Farè,et al.  Vascular Tissue Engineering: Recent Advances in Small Diameter Blood Vessel Regeneration , 2014 .

[29]  Xue Geng,et al.  The in vitro and in vivo biocompatibility evaluation of heparin-poly(ε-caprolactone) conjugate for vascular tissue engineering scaffolds. , 2012, Journal of biomedical materials research. Part A.

[30]  Yakai Feng,et al.  Electrospun hemocompatible PU/gelatin-heparin nanofibrous bilayer scaffolds as potential artificial blood vessels , 2012, Macromolecular Research.

[31]  Jun Zhang,et al.  Endothelialization and patency of RGD-functionalized vascular grafts in a rabbit carotid artery model. , 2012, Biomaterials.

[32]  Yadong Wang,et al.  Fast degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neo-artery , 2011, Nature Medicine.

[33]  R. Gurny,et al.  Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model. , 2012, Biomaterials.

[34]  Ryuji Kato,et al.  Novel small-caliber vascular grafts with trimeric Peptide for acceleration of endothelialization. , 2012, The Annals of thoracic surgery.

[35]  L. Ye,et al.  Heparin-Conjugated PCL Scaffolds Fabricated by Electrospinning and Loaded with Fibroblast Growth Factor 2 , 2011, Journal of biomaterials science. Polymer edition.

[36]  Anthony Atala,et al.  The in vivo stability of electrospun polycaprolactone-collagen scaffolds in vascular reconstruction. , 2009, Biomaterials.

[37]  M. Avci-Adali,et al.  New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialisation of blood contacting materials. , 2008, Biomaterials.

[38]  Lisbeth Grøndahl,et al.  Controlled release of heparin from poly(ε-caprolactone) electrospun fibers , 2006 .

[39]  Seeram Ramakrishna,et al.  Electrospinning and mechanical characterization of gelatin nanofibers , 2004 .